3-Bromo-4-methyl-5-nitropyridine

Catalog No.: 
ACCSIB471
CAS No.: 
69872-15-7
Molecular Formula: 
C6H5BrN2O2
Molecular Weight: 
217.02
3-Bromo-4-methyl-5-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$53.00In stockIn stock
25g97%$130.00In stockIn stock
100g97%$520.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-4-methyl-5-nitropyridine
IUPAC Name3-bromo-4-methyl-5-nitropyridine
MDL No.MFCD11847767
Molecular FormulaC6H5BrN2O2
Molecular Weight217.02
SMILESO=[N+](C1=CN=CC(Br)=C1C)[O-]
InChI KeyWFCIQRPATFRBOY-UHFFFAOYSA-N
SynonymAB64738 | STL555458 | AS-18513 | 3-Bromo-4-methy-5nitro-pyridine | DTXSID00500853 | CS-W003806 | AU-004/43508239 | MFCD11847767 | A836676 | AKOS007930528 | AM20061453 | SY024652 | 3-bromo-5-nitro-4-methylpyridine | AC-23257 | EN300-129508 | Pyridine, 3-br
CAS No.69872-15-7
PubChem CID12510054

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P501

Synthetic Route by SureRoute

1. ACCSIB471 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOUX123 route compound structure diagram
    ACLOUX123100367-40-6 In Stock
  2. Then
  3. ACCSIB471 route product structure diagram
    ACCSIB47169872-15-7 In Stock
Inquiry

2. ACCSIB471 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCQVJ618 route compound structure diagram
    ACCQVJ618884495-15-2 In Stock
  2. Then
  3. ACCSIB471 route product structure diagram
    ACCSIB47169872-15-7 In Stock
Inquiry

3. ACCSIB471 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCSIB471 route product structure diagram
    ACCSIB47169872-15-7 In Stock
Inquiry

Comments (0)